Cheng‐Yi Wang
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
Papers in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research 16
- Respiratory Support and Mechanisms 9
- Inhalation and Respiratory Drug Delivery 5
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 5
-
- COVID-19 Clinical Research Studies 9
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Po‐Ren Hsueh (7 shared papers)Chih-Cheng Lai (3 shared papers)Chih‐Cheng Lai (39 shared papers)Wen‐Chien Ko (3 shared papers)Ya‐Hui Wang (28 shared papers)Yahui Wang (1 shared paper)Chao‐Hsien Chen (18 shared papers)Chong‐Jen Yu (18 shared papers)
- Journals
- International Journal of COPD (8 papers)Journal of Microbiology Immunology and Infection (7 papers)PLoS ONE (4 papers)Journal of Infection and Public Health (3 papers)Expert Review of Clinical Pharmacology (2 papers)
- Partner nations
- TaiwanUnited StatesNetherlands
In The Last Decade
Cheng‐Yi Wang
85 papers receiving 2.7k citations
Cheng‐Yi Wang's Hit Papers
Peers
Comparison fields: 5 of 154
- Infectious Diseases 845
- Applied Microbiology and Biotechnology 84
- Modeling and Simulation 140
- General Dentistry 41
- Nephrology 135
Countries citing papers authored by Cheng‐Yi Wang
This map shows the geographic impact of Cheng‐Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Yi Wang more than expected).
Fields of papers citing papers by Cheng‐Yi Wang
This network shows the impact of papers produced by Cheng‐Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Yi Wang. The network helps show where Cheng‐Yi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng‐Yi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 90 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths Hit paper breakdown → | 2020 | 627 |
| 2 | 2020 | 348 | |
| 3 | 2020 | 272 | |
| 4 | 2014 | 131 | |
| 5 | 2014 | 85 | |
| 6 | 2020 | 71 | |
| 7 | 2018 | 64 | |
| 8 | 2012 | 58 | |
| 9 | 2021 | 54 | |
| 10 | 2022 | 50 | |
| 11 | 2014 | 47 | |
| 12 | 2022 | 43 | |
| 13 | 2014 | 42 | |
| 14 | 2022 | 39 | |
| 15 | 2012 | 39 | |
| 16 | 2010 | 35 | |
| 17 | 2018 | 32 | |
| 18 | 2015 | 32 | |
| 19 | 2023 | 30 | |
| 20 | 2014 | 29 |
About Cheng‐Yi Wang
Cheng‐Yi Wang is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Physiology, Epidemiology and Molecular Biology, having authored 90 papers that have together received 2.8k indexed citations. Recurring topics across this work include Chronic Obstructive Pulmonary Disease (COPD) Research (16 papers), Respiratory Support and Mechanisms (9 papers), COVID-19 Clinical Research Studies (9 papers), Asthma and respiratory diseases (7 papers), Inhalation and Respiratory Drug Delivery (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Obstructive Sleep Apnea Research (5 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Infectious Diseases (845 citations), Applied Microbiology and Biotechnology (84 citations), Modeling and Simulation (140 citations), General Dentistry (41 citations) and Nephrology (135 citations). Cheng‐Yi Wang has collaborated with scholars based in Taiwan, United States and Netherlands. Frequent co-authors include Po‐Ren Hsueh, Chih-Cheng Lai, Chih‐Cheng Lai, Wen‐Chien Ko, Ya‐Hui Wang, Yahui Wang, Chao‐Hsien Chen, Chong‐Jen Yu, Hao‐Chien Wang and Kuen‐Feng Chen. Their work appears in journals such as International Journal of COPD, Journal of Microbiology Immunology and Infection, PLoS ONE, Journal of Infection and Public Health and Expert Review of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.